REGISTERED NUMBER: 10974208 (England and Wales)

Financial Statements

for the Year Ended 31 March 2025

for

JS CARDIOLOGY SERVICES LIMITED

Page

Balance Sheet

1

FIXED ASSETS

36,762

10,368

CURRENT ASSETS

623,740

521,067

CREDITORS

Amounts falling due within one year

(62,439

)

(73,394

)

NET CURRENT ASSETS

561,301

447,673

TOTAL ASSETS LESS CURRENT LIABILITIES

598,063

458,041

CREDITORS

Amounts falling due after more than one year

(7,787

)

(17,516

)

NET ASSETS

590,276

440,525

CAPITAL AND RESERVES

590,276

440,525

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

JS Cardiology Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

10974208

Registered office:

4th Floor

166 College Road

Harrow on the Hill

Middlesex

HA1 1BH

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2024 - 1 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 12 September 2025 and were signed by:

Dr J S Sehmi - Director